TBD-11
- Generic Name
- TBD-11
A Trial in Healthy Adult Participants to Evaluate the Safety, Tolerability, and Behavior in the Body of TBD11
- First Posted Date
- 2024-11-27
- Last Posted Date
- 2025-05-07
- Lead Sponsor
- Bill & Melinda Gates Medical Research Institute
- Target Recruit Count
- 108
- Registration Number
- NCT06707142
- Locations
- 🇺🇸
Celerion, Lincoln, Nebraska, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath